<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>STING and LTβR activation &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/sting-and-lt%ce%b2r-activation/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 30 Sep 2025 16:46:41 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>STING and LTβR activation &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Johns Hopkins Researchers Discover Innovative Immune System Enhancement to Combat Cancer Cells</title>
		<link>https://bioengineer.org/johns-hopkins-researchers-discover-innovative-immune-system-enhancement-to-combat-cancer-cells/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 30 Sep 2025 16:46:18 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Immune system enhancement]]></category>
		<category><![CDATA[immune-cold tumor therapy]]></category>
		<category><![CDATA[Johns Hopkins cancer research]]></category>
		<category><![CDATA[STING and LTβR activation]]></category>
		<category><![CDATA[tertiary lymphoid structures]]></category>
		<guid isPermaLink="false">https://bioengineer.org/johns-hopkins-researchers-discover-innovative-immune-system-enhancement-to-combat-cancer-cells/</guid>

					<description><![CDATA[A groundbreaking study from Johns Hopkins All Children’s Hospital unveils a novel strategy to harness the natural immune system in combating cancer, offering promising avenues to prevent tumor recurrence and enhance survival outcomes. Utilizing sophisticated mouse models of breast, pancreatic, and muscle cancers, this research demonstrates the therapeutic potential of crafting an immune-conducive tumor microenvironment, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">273820</post-id>	</item>
	</channel>
</rss>
